PE-backed CMO expands syringe filling capabilities

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/NikiLitov)
(Image: Getty/NikiLitov)
Grand River Aseptic Manufacturing (GRAM) has purchased a new syringe filler to help meet "the rising demand" for parenteral development and manufacturing services.

The Colanar FSV syringe filler will use the facility's existing single-use systems and will support both small molecule APIs and biologics projects at its FDA-inspected, cGMP-compliant manufacturing facility in Grand Rapids, MI.

The syringe filler – expected to be qualified and operational by the second quarter of 2018 – is also capable of handling cartridges, according to the parenteral contract manufacturing organization (CMO).

"GRAM purchased the syringe filler to support our client’s product growth,"​ Steve Nole, director of operations at GRAM, told us.

The company has also seen a significant increase in request for pre-filled syringes over the last six to 12 months, he said.

When asked how GRAM plans to continue investing to meet this demand, Nole explained the company is building a new facility that will include a new filling suite with a high-speed integrated fill line, "utilizing best-in-class isolator technology."

The new facility is expected to open in 2020.

GRAM recently announced an investment​ from the private equity (PE) firm Arlington Capital Partners. According to the company, the new funding will enable it to expand and add capacity to meet a “the rising demand”​ for parenteral development and manufacturing services.

Related news

Show more

Related products

show more

Q&A: Effective Drug Product Process Development

Q&A: Effective Drug Product Process Development

Catalent Pharma Solutions | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Related suppliers

Follow us


View more